Dr. Richer, speaking at his 4th annual Nutrition & The Eye conference, April 16-17, hosted by the College of Optometry at the University of Missouri in St. Louis, says molecular medicine is beginning to provide hope for patients with declining sight when all other therapies have been exhausted.
"These nutritional molecules have begun to be rigorously studied around the world in cardiology , cancer research and some human studies", Dr Richer reported.
Dr. Richer has now accumulated a growing number of otherwise hopeless cases that retina specialists and other ophthalmologists referred to his center. These low-cost preventive molecular medicine approaches have worked without fail so far, he says. Dr. Richer presented six separate cases where molecular medicine sometimes improved functional vision within days, which was unexpected.
A recent case, says Dr. Richer, is an 88-year old woman with macular degeneration, an age-related eye disorder that robs seniors of their central vision.[ NOT TRUE – REFUSED TX--whom retinal specialists said was beyond any help offered by conventional medicines and surgery—just omit]. Employing a molecular medicine regimen, this hospitalized woman regained her ability to see faces, read a menu and visualize her handwriting in just four days. Her vision improvement was in both eyes says Dr. Richer. "A second 88-year old patient, this time with "dry" macular degeneration, took 10 weeks to see clinical improvement, but by 20 weeks the retina appeared to return to a more youthful appearance with 20/20 vision."
Dr. Richer says, typically in the cases he has monitored, blind spots (called scotomas) disappear, time to recover from bright light (glare recovery test) is reduced, and contrast vision (shades of grey) as well as visual acuity (ability to see letters on a chart) generally improve within 3-6 weeks on a molecular medicine regimen that provides small molecules that bind to (chelate) to minerals such as copper, iron and calcium.
In recent months a growing body of scientific studies point to the age-related over-accumulation of these minerals as an underlying cause of eye problems in the aged.
Dr. Richer selected a nutriceutical mixture of vitamins and small molecules (Longevinex®) extracted from herbs and vitamins to produce these rapid improvements in functional vision because of its extensive testing and proven ability to favorably alter genes in a superior manner to other available nutriceuticals.
He says the human eye apparently has untapped regenerative capacity that can be activated with molecules found in nature. There is a growing body of science which points to regeneration of tissue via the use of molecular medicine to promote the survival of endogenously-produced stem cells. Dr. Richer believes this is what is actually happening in these cases, "and if scientifically proven, this approach has obvious advantages when used alone or in conjunction with injected stem cells or organ transplants", he emphasizes.
Dr. Richer says age-related eye problems may not be inevitably progressive. There is new-found hope for recovery of lost vision, regardless of the age of the patients.
Dr. Richer has no financial interest in the products used in his investigations. To learn more, visit Dr. Richer's website at www.eyedrricher.com
Stuart Richer | EurekAlert!
NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University
How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine